Activation of systemic antitumor immunity via TRAIL-induced apoptosis

TNF-related apoptosis-inducing ligand (TRAIL) continues to be intently studied as a cancer therapeutic because of its selective tumoricial activity. We have been interesting in evaluating the ability of TRAIL to induce systemic antitumor immunity through the generation of apoptotic tumor cells. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Britnie R., Griffith, Thomas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494637/
https://www.ncbi.nlm.nih.gov/pubmed/23170271
http://dx.doi.org/10.4161/onci.20638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494637/
https://www.ncbi.nlm.nih.gov/pubmed/23170271
http://dx.doi.org/10.4161/onci.20638

Ejemplares similares